mannitol has been researched along with Leukocytopenia in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
GRAF, F; TAKACSI NAGY, L | 1 |
Hegedüs, L; Horváth, IP; Jarman, M; Somfai-Relle, S | 1 |
Hosoya, T; Nakai, O; Takahama, H; Takanashi, T; Yamada, K | 1 |
Brunner, K; Cooper, R; Ellison, RR; Holland, JF; Levy, R; Mick, R; Schwartz, JM; Silver, RT | 1 |
Kelemen, E | 1 |
Alberto, P; Maurice, PA | 1 |
Baccarani, M; Tura, S | 1 |
1 trial(s) available for mannitol and Leukocytopenia
Article | Year |
---|---|
A comparative study of dibromomannitol and busulfan in the treatment of chronic myeloid leukemia. A study of cancer and leukemia group B.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Busulfan; Child; Child, Preschool; Clinical Trials as Topic; Female; Humans; Leukemia, Myeloid; Leukocyte Count; Leukopenia; Male; Mannitol; Middle Aged; Mitobronitol; Prognosis; Prospective Studies; Random Allocation; Thrombocytopenia | 1987 |
6 other study(ies) available for mannitol and Leukocytopenia
Article | Year |
---|---|
[CLINICAL TESTING OF THE THERAPEUTIC EFFECT OF 1,6-BIS(2-MESYLOXYETHYLAMINO) 1,6-DIDESOXY-D-MANNITOL DI-HC1 (R 49)].
Topics: Antineoplastic Agents; Blood Cell Count; Blood Platelets; Hodgkin Disease; Leukemia; Leukemia, Lymphoid; Leukopenia; Lymphadenitis; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mannitol; Mannomustine; Neoplasms; Radiography, Thoracic; Sarcoma; Thrombocytopenia; Toxicology | 1964 |
Toxicity, antitumour and haematological effects of 1,2-anhydro-6-bromogalactitol and d-mannitol: a comparison with the related dibromo- and dianhydro-derivatives.
Topics: Animals; Antineoplastic Agents; Carcinoma 256, Walker; Dianhydrogalactitol; Lethal Dose 50; Leukopenia; Mannitol; Mice; Mitobronitol; Mitolactol; Rats | 1982 |
[Intra-arterial chemotherapy of malignant glioma after osmotic blood-brain barrier disruption].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain Neoplasms; Evaluation Studies as Topic; Female; Fluorouracil; Glioma; Humans; Infusions, Intra-Arterial; Interferon Type I; Leukopenia; Male; Mannitol; Middle Aged; Nimustine; Osmotic Pressure; Remission Induction; Thrombocytopenia | 1989 |
Granulocyte alkaline phosphatase activity: a measure of the emergence time of mature marrow neutrophils?
Topics: Aged; Agranulocytosis; Alkaline Phosphatase; Bone Marrow; Bone Marrow Cells; Bone Marrow Examination; Bromine; Carbutamide; Cyclophosphamide; Diabetes Mellitus; Female; Hemangiosarcoma; Humans; Leukocyte Count; Leukopenia; Male; Mannitol; Middle Aged; Neutrophils; Sepsis; Vincristine | 1973 |
[Results of long-term treatment of polycythemia vera with busulfan (Myleran) or dibromomannitol (Myelobromol): analysis of 4 clinical cases observed and treated during more than 7 years].
Topics: Aged; Antineoplastic Agents; Busulfan; Female; Follow-Up Studies; Humans; Leukopenia; Long-Term Care; Mannitol; Middle Aged; Polycythemia Vera; Thrombocytopenia | 1969 |
The management of polycythaemia vera with dibromomannitol.
Topics: Adult; Aged; Blood Cell Count; Blood Platelets; Female; Hematocrit; Humans; Leukopenia; Male; Mannitol; Middle Aged; Polycythemia Vera; Spleen; Splenomegaly; Thrombocytopenia | 1970 |